Predictors of the Ability to Protect the Airway in Long-term Ventilated Patients
Study Details
Study Description
Brief Summary
First part of a 2 part study with the same IRB protocol #, and labeled 'A'. Investigators hypothesized that clinical muscle strength assessment (manual muscle testing) predicts the ability to protect the airway during swallowing in long-term ventilated subjects. More specifically, the investigators hypothesized that low muscle strength is associated with the inability to clear secretions from the peri-laryngeal area (valleculae and pyriform sinus residue scale (VPSR scale [NRS: 0-4] of > 1) and entering the materials into airway (PAS scale [1-8]> 1), which should predispose to endotracheal aspiration.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Long term ventilated subjects Muscle Strength Measurement, ventilator |
Other: Muscle Strength Measurement
MRC score (0-60) is a clinical assessment of muscle power on abduction of the arm, flexion of the forearm, extension of the wrist, flexion of the leg, extension of the knee and dorsal flexion of the foot with the score of (0-5) on each measurement
Other: Ventilator
A mechanical ventilator is used to assist or replace spontaneous breathing.
|
Outcome Measures
Primary Outcome Measures
- Muscle Strength [Within 24 hours of fiberoptic endoscopic evaluation of swallow]
We use Medical Research Council (MRC) scale (0-60) to evaluate the degree of muscle weakness in the tracheostomized patients.
Secondary Outcome Measures
- Number of Patients With Muscle Weakness (MRC<48) Who Developed Clinical Aspiration [Within 3 month follow-up]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients admitted to the Respiratory Acute Care Unit and Surgical Intensive Care Unit, units with a mixed collection of long term ventilated patients in a major academic teaching hospital.
-
Age over 18 years.
-
Long-term ventilated patients (>10 days) with tracheotomies
Exclusion Criteria:
-
Decreased level of consciousness as defined by a Richmond Agitation Sedation Scale (RASS) of 0.
-
Non-cooperative patient, CAM score positive for delirium.
-
For women: pregnancy.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Massachusetts general Hospital | Boston | Massachusetts | United States | 02114 |
Sponsors and Collaborators
- Massachusetts General Hospital
Investigators
- Principal Investigator: Matthias Eikermann, MD, PhD, MGH, Harvard Medical School
Study Documents (Full-Text)
None provided.More Information
Publications
- Butler SG, Stuart A, Markley L, Rees C. Penetration and aspiration in healthy older adults as assessed during endoscopic evaluation of swallowing. Ann Otol Rhinol Laryngol. 2009 Mar;118(3):190-8.
- Kleyweg RP, van der Meché FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve. 1991 Nov;14(11):1103-9.
- Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL. A penetration-aspiration scale. Dysphagia. 1996 Spring;11(2):93-8.
- 2010P001919A
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Long-term Ventilated Subjects |
---|---|
Arm/Group Description | Long-term (>10 days hours) ventilated subjects were included. |
Period Title: Overall Study | |
STARTED | 30 |
COMPLETED | 30 |
NOT COMPLETED | 0 |
Baseline Characteristics
Arm/Group Title | Baseline Population |
---|---|
Arm/Group Description | Thirty long-term ventilated patients admitted in two intensive care units at Massachusetts General Hospital. |
Overall Participants | 30 |
Age (Count of Participants) | |
<=18 years |
0
0%
|
Between 18 and 65 years |
23
76.7%
|
>=65 years |
7
23.3%
|
Age (years) [Mean (Standard Deviation) ] | |
Mean (Standard Deviation) [years] |
55
(14)
|
Sex: Female, Male (Count of Participants) | |
Female |
14
46.7%
|
Male |
16
53.3%
|
Region of Enrollment (participants) [Number] | |
United States |
30
100%
|
Outcome Measures
Title | Muscle Strength |
---|---|
Description | We use Medical Research Council (MRC) scale (0-60) to evaluate the degree of muscle weakness in the tracheostomized patients. |
Time Frame | Within 24 hours of fiberoptic endoscopic evaluation of swallow |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Muscle Strength Measurement |
---|---|
Arm/Group Description | Muscle Strength Measurement : MRC score (0-60) is a clinical assessment of muscle power on abduction of the arm, flexion of the forearm, extension of the wrist, flexion of the leg, extension of the knee and dorsal flexion of the foot with the score of (0-5) on each measurement |
Measure Participants | 30 |
Clinically significant muscle weakness (<48) |
20
66.7%
|
No clinically significant muscle weakness (>=48) |
10
33.3%
|
Title | Number of Patients With Muscle Weakness (MRC<48) Who Developed Clinical Aspiration |
---|---|
Description | |
Time Frame | Within 3 month follow-up |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Muscle Strength Measurement |
---|---|
Arm/Group Description | Muscle Strength Measurement : MRC score (0-60) is a clinical assessment of muscle power on abduction of the arm, flexion of the forearm, extension of the wrist, flexion of the leg, extension of the knee and dorsal flexion of the foot with the score of (0-5) on each measurement |
Measure Participants | 20 |
Symptomatic aspiration |
14
46.7%
|
No symptomatic aspiration |
6
20%
|
Adverse Events
Time Frame | ||
---|---|---|
Adverse Event Reporting Description | ||
Arm/Group Title | Long-term Ventilated Subjects | |
Arm/Group Description | 30 consented long-term ventilated patients | |
All Cause Mortality |
||
Long-term Ventilated Subjects | ||
Affected / at Risk (%) | # Events | |
Total | / (NaN) | |
Serious Adverse Events |
||
Long-term Ventilated Subjects | ||
Affected / at Risk (%) | # Events | |
Total | 0/30 (0%) | |
Other (Not Including Serious) Adverse Events |
||
Long-term Ventilated Subjects | ||
Affected / at Risk (%) | # Events | |
Total | 0/30 (0%) |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Hooman Mirzakhani |
---|---|
Organization | Massachusetts General Hospital |
Phone | 617-291-9779 |
hmirzakhani@partners.org |
- 2010P001919A